Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
about
Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy.From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo.Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE
P2860
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@en
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@nl
type
label
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@en
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@nl
prefLabel
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@en
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
@nl
P2860
P1433
P1476
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
@en
P2093
Saad S Kenderian
P2860
P2888
P304
P356
10.1007/S40259-017-0247-0
P50
P577
2017-12-01T00:00:00Z